Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer.
Saved in:
| Title: | Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer. |
|---|---|
| Authors: | Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Munters AR; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Kämpe A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Tesi B; Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Genetics, Karolinska Institutet, Stockholm, Sweden., Bondeson ML; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Ladenvall C; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Eriksson D; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden daniel.eriksson@igp.uu.se.; Department of Clinical Genetics, Akademiska Sjukhuset, Uppsala, Sweden. |
| Source: | Journal of medical genetics [J Med Genet] 2024 Jan 19; Vol. 61 (2), pp. 150-154. Date of Electronic Publication: 2024 Jan 19. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
